CEL vs. EAH, VLG, ANCR, AGY, BXP, APH, BVC, DXRX, SCLP, and FARN
Should you be buying Celadon Pharmaceuticals stock or one of its competitors? The main competitors of Celadon Pharmaceuticals include ECO Animal Health Group (EAH), Venture Life Group (VLG), Animalcare Group (ANCR), Allergy Therapeutics (AGY), Beximco Pharmaceuticals (BXP), Alliance Pharma (APH), BATM Advanced Communications (BVC), Diaceutics (DXRX), Scancell (SCLP), and Faron Pharmaceuticals Oy (FARN). These companies are all part of the "medical" sector.
ECO Animal Health Group (LON:EAH) and Celadon Pharmaceuticals (LON:CEL) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, profitability, analyst recommendations, dividends, community ranking and media sentiment.
In the previous week, Celadon Pharmaceuticals' average media sentiment score of 0.00 equaled ECO Animal Health Group'saverage media sentiment score.
95.9% of ECO Animal Health Group shares are held by institutional investors. Comparatively, 5.5% of Celadon Pharmaceuticals shares are held by institutional investors. 17.0% of ECO Animal Health Group shares are held by insiders. Comparatively, 73.2% of Celadon Pharmaceuticals shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
ECO Animal Health Group has higher revenue and earnings than Celadon Pharmaceuticals. ECO Animal Health Group is trading at a lower price-to-earnings ratio than Celadon Pharmaceuticals, indicating that it is currently the more affordable of the two stocks.
ECO Animal Health Group received 288 more outperform votes than Celadon Pharmaceuticals when rated by MarketBeat users. However, 100.00% of users gave Celadon Pharmaceuticals an outperform vote while only 75.65% of users gave ECO Animal Health Group an outperform vote.
Celadon Pharmaceuticals has a net margin of 0.00% compared to Celadon Pharmaceuticals' net margin of -1.83%. Celadon Pharmaceuticals' return on equity of -0.24% beat ECO Animal Health Group's return on equity.
Celadon Pharmaceuticals has a consensus price target of GBX 222.50, indicating a potential upside of 109.03%. Given ECO Animal Health Group's higher possible upside, analysts plainly believe Celadon Pharmaceuticals is more favorable than ECO Animal Health Group.
Summary
ECO Animal Health Group and Celadon Pharmaceuticals tied by winning 7 of the 14 factors compared between the two stocks.
Get Celadon Pharmaceuticals News Delivered to You Automatically
Sign up to receive the latest news and ratings for CEL and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding CEL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Celadon Pharmaceuticals Competitors List
Related Companies and Tools
